SULFASALAZINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sulfasalazine, and when can generic versions of Sulfasalazine launch?
Sulfasalazine is a drug marketed by Nuvo Pharms Inc, Watson Labs, Chartwell, Epic Pharma Llc, Sun Pharm Industries, and Superpharm. and is included in ten NDAs.
The generic ingredient in SULFASALAZINE is sulfasalazine. There are ten drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sulfasalazine
A generic version of SULFASALAZINE was approved as sulfasalazine by WATSON LABS on December 31st, 1969.
Summary for SULFASALAZINE
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 10 |
Finished Product Suppliers / Packagers: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 142 |
Clinical Trials: | 98 |
Patent Applications: | 4,187 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SULFASALAZINE |
What excipients (inactive ingredients) are in SULFASALAZINE? | SULFASALAZINE excipients list |
DailyMed Link: | SULFASALAZINE at DailyMed |
Recent Clinical Trials for SULFASALAZINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rutgers, The State University of New Jersey | Phase 2 |
University of Zurich | Phase 1/Phase 2 |
Swiss National Science Foundation | Phase 1/Phase 2 |
Pharmacology for SULFASALAZINE
Drug Class | Aminosalicylate |
Medical Subject Heading (MeSH) Categories for SULFASALAZINE
Anatomical Therapeutic Chemical (ATC) Classes for SULFASALAZINE
US Patents and Regulatory Information for SULFASALAZINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nuvo Pharms Inc | SULFASALAZINE | sulfasalazine | TABLET, DELAYED RELEASE;ORAL | 075339-001 | Jan 11, 2002 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Superpharm | SULFASALAZINE | sulfasalazine | TABLET;ORAL | 089339-001 | Oct 26, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Epic Pharma Llc | SULFASALAZINE | sulfasalazine | TABLET;ORAL | 086184-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | SULFASALAZINE | sulfasalazine | TABLET;ORAL | 084964-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | SULFASALAZINE | sulfasalazine | TABLET, DELAYED RELEASE;ORAL | 088052-001 | May 24, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |